Antipsychotics and Antimanic Agents: Medicinal Chemistry Study Guide

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering typical and atypical antipsychotics, SAR, pharmacokinetics, side effects, and antimanic agents from PHAR 441 lecture.

22 Terms

1
New cards

Psychosis

Mental disorders involving a loss of contact with reality that affect approximately 1%1\% of people, pathologically linked to the over-activity of dopaminergic neurons in the brain.

2
New cards

Typical Antipsychotic Agents

First-generation neuroleptic drugs (e.g., Phenothiazines and Butyrophenones) that primarily function by blocking dopamine receptors, particularly postsynaptic D2D_2 receptors in the mesolimbic pathway.

3
New cards

Extrapyramidal Side Effects (EPS)

Movement disorders caused by dopamine receptor blockade in the nigrostriatal pathway, commonly associated with typical antipsychotics and including acute dystonia and tardive dyskinesia.

4
New cards

Acute Dystonia

An extrapyramidal side effect characterized by involuntary movements such as muscle spasms and a protruding tongue, typically occurring within the first few weeks of treatment and declining over time.

5
New cards

Tardive Dyskinesia

An extrapyramidal side effect characterized by impairment of voluntary movements, frequently affecting the face and tongue, which develops over months to years of antipsychotic treatment and is often irreversible.

6
New cards
<p>Phenothiazines</p>

Phenothiazines

A class of typical antipsychotics with a tricyclic 6-6-6 system in which two benzene rings are linked by sulfur and nitrogen atoms, requiring an unbranched 3-carbon chain between the two nitrogen atoms for optimal antipsychotic activity.

7
New cards

Chlorpromazine

A low-potency typical phenothiazine antipsychotic (t1/2=15t_{1/2} = 15 to 30 hours30\,hours) with low EPS incidence, significant sedative and hypotensive properties, and an indication for symptomatic relief of nausea, vomiting, and hiccups.

8
New cards
<p>Piperidine Phenothiazine Subgroup</p>

Piperidine Phenothiazine Subgroup

A subgroup of phenothiazines containing a six-membered saturated ring with one nitrogen atom, associated with lower EPS, high anticholinergic activity, and sedative/hypnotic properties.

9
New cards

Thioridazine

A piperidine subgroup phenothiazine (t1/2=7t_{1/2} = 7 to 13 hours13\,hours) featuring low EPS and high anticholinergic activity, which can cause pigmentary retinopathy at high doses.

10
New cards

Mesoridazine

The active S-oxidation metabolite of thioridazine (t1/2=24t_{1/2} = 24 to 48 hours48\,hours) that shares thioridazine's clinical properties but does not cause pigmentary retinopathy.

11
New cards
<p>Piperazine Phenothiazine Subgroup</p>

Piperazine Phenothiazine Subgroup

A subgroup of phenothiazines featuring a six-membered ring with two nitrogen atoms; it minimizes anticholinergic side effects relative to other subgroups but carries a higher risk of EPS.

12
New cards

Fluphenazine

The most potent antipsychotic phenothiazine on a milligram basis (t1/2=15t_{1/2} = 15 to 30 hours30\,hours), containing a piperazine side chain that reduces anticholinergic effects while increasing EPS risk.

13
New cards
<p>Fluphenazine Decanoate</p>

Fluphenazine Decanoate

A lipid-soluble fatty acid ester prodrug of fluphenazine formulated for long-acting depot IM injection (t1/2=6.8t_{1/2} = 6.8 to 9.6 days9.6\,days), hydrolysable by blood esterases.

14
New cards

Butyrophenones

A class of high-potency typical antipsychotic agents (e.g., Haloperidol) characterized by strong affinity for D2D_2 receptors and a high incidence of extrapyramidal side effects.

15
New cards

Haloperidol

A potent butyrophenone antipsychotic (1 mg1\,mg is equivalent to 50 mg50\,mg chlorpromazine; t1/2=10t_{1/2} = 10 to 30 hours30\,hours) used in schizophrenia, psychoses from brain damage, and mania termination, but associated with high EPS.

16
New cards

Haloperidol Lactate

A polar, hydrophilic salt formulation of haloperidol combined with lactic acid, administered at 22 to 5 mg5\,mg via IM or IV injection.

17
New cards

Haldol Decanoate

A lipophilic ester prodrug of haloperidol administered as a depot IM injection in sesame oil every 22 to 4 weeks4\,weeks (t1/2≈3 weekst_{1/2} \approx 3\,weeks); it must never be administered IV.

18
New cards

Atypical Antipsychotic Agents

Second-generation antipsychotics that combine dopamine D2D_2 receptor antagonism with serotonin 5-HT2A5\text{-HT}_{2A} receptor antagonism, offering effective symptom control with a lower incidence of EPS.

19
New cards

Benzazepine Derivatives

A class of atypical antipsychotics featuring a 6-7-6 tricyclic ring system (e.g., Clozapine, Olanzapine, Quetiapine) that display low EPS and high affinity for 5-HT2A5\text{-HT}_{2A} receptors relative to D2D_2 receptors.

20
New cards
<p>Aripiprazole</p>

Aripiprazole

An atypical antipsychotic containing quinolinone and arylpiperazine groups that acts as a partial agonist at D2D_2 receptors, featuring low EPS and an elimination half-life of 75 hours75\,hours.

21
New cards

Dehydroaripiprazole

The active metabolite of aripiprazole generated via CYP3A4 and CYP2D6 oxidation, possessing an elimination half-life of 94 hours94\,hours.

22
New cards

Lithium Salts

Antimanic agents (specifically Lithium Carbonate and Lithium Citrate) that mimic sodium ions to enter sodium pump pathways without maintaining membrane potential, thereby preventing excessive neurotransmitter release in bipolar disorder.